Background Image
Menu

News: 2017

Catapult portfolio company, BWB, joins CAF Group

14 July 2017

Catapult portfolio company, BWB, joins CAF Group

Catapult is pleased to announce that its portfolio business, BWB Consulting, one of the UK’s leading design engineering consultancies, has become part of the global transport engineering giant CAF Group. The transaction, which will see BWB embark on significant expansion...

Abzena and OBI Pharma sign ThioBridge™ licence agreement

11 July 2017

Abzena and OBI Pharma sign ThioBridge™ licence agreement

Cambridge, UK, Taipei, Taiwan, 11 July 2017 – Abzena plc (AIM: ABZA, ‘Abzena’ or the ‘Group’), the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has signed a...

BT Sport extends Yospace Dynamic Ad Insertion deal

6 July 2017

BT Sport extends Yospace Dynamic Ad Insertion deal

BT Sport has agreed a multi-year extension to its relationship with Dynamic Ad Insertion (DAI) technology provider Yospace. The announcement follows what BT Sport called a successful 12-month period, during which Yospace enabled advert placement in over 700 major sporting events...

BWB Wins Technology Champion Award

5 July 2017

BWB Wins Technology Champion Award

BWB’s focus on driving digital innovation has been recognised at a prestigious industry award ceremony in London. We've been crowned Technology Champions at the recent ACE Consultancy and Engineering Awards, an event that showcases the very best that the built environment...

PeproStat Phase IIb study passes recruitment mid-point ahead of schedule – Top line results brought forward to Q4 2017

27 June 2017

PeproStat Phase IIb study passes recruitment mid-point ahead of schedule – Top line results brought forward to Q4 2017

London, UK – 21 June 2017: Ergomed plc (LSE: ERGO) (‘Ergomed’ or the ‘Company’), a company dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, today announces that its Phase IIb...

Auto Windscreens Joins r2c’s Digital Platform

20 June 2017

Auto Windscreens Joins r2c’s Digital Platform

Auto Windscreens has become the first windscreen provider to join the r2c Online network, adopting its digital compliance management platform. Alongside the platform, the UK’s leading automotive glass repair and replacement provider, has also signed up to the i2i...

Cytox raises £2.6m led by Catapult Ventures to launch predictive test for Alzheimer’s Disease

15 June 2017

Cytox raises £2.6m led by Catapult Ventures to launch predictive test for Alzheimer’s Disease

Alderley Park, UK – 14 June 2017. Cytox, a leader in genetic testing for Alzheimer’s Disease, today announced that it has raised £2.6m to fund the commercial launch and international roll out of its novel service. The funding round was led by the GM&C Life...

Oxford BioTherapeutics Appoints Senior Clinical Biotech Executive as Non-Executive Director

14 June 2017

Oxford BioTherapeutics Appoints Senior Clinical Biotech Executive as Non-Executive Director

Oxford, UK; San Jose, CA – 13 June 2017 – Oxford BioTherapeutics Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and antibody-drug conjugate based therapies, has appointed Dr John McHutchison, Executive Vice...

Proveca and Tanner Pharma Initiate Global Managed Access Program for Sialanar®

13 June 2017

Proveca and Tanner Pharma Initiate Global Managed Access Program for Sialanar®

CHARLOTTE, N.C.--(BUSINESS WIRE)--Tanner Pharma Group’s Managed Access Programs (MAP) division and Proveca have agreed to launch a Managed Access Program for an oral formulation of glycopyrronium (Sialanar®) outside Europe and the USA. Sialanar is for the treatment of...

Bioverativ to acquire True North Therapeutics and the Abzena Inside portfolio product, TNT009

6 June 2017

Bioverativ to acquire True North Therapeutics and the Abzena Inside portfolio product, TNT009

Cambridge, UK, 24 May 2017 – Abzena plc (AIM: ABZA, ‘Abzena’ or the ‘Group’), the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, notes the announcement from Bioverativ...